Northern Trust
AGL icon

Northern Trust’s Agilon Health AGL Stock Holding History

Northern Trust’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
103,432
+7,332
+8% +$480K ﹤0.01% 2167
2026
Q1 		$760K Buy
96,100
+4,653
+5% +$75.2K ﹤0.01% 3453
2025
Q4 		$1.57M Sell
91,447
-14,523
-14% -$282K ﹤0.01% 3132
2025
Q3 		$2.73M Sell
105,970
-2,379
-2% -$89.9K ﹤0.01% 2860
2025
Q2 		$6.23M Sell
108,349
-5,440
-5% -$436K ﹤0.01% 2342
2025
Q1 		$12.3M Sell
113,789
-4,705
-4% -$409K ﹤0.01% 1920
2024
Q4 		$5.63M Buy
118,494
+13,612
+13% +$823K ﹤0.01% 2439
2024
Q3 		$10.3M Buy
104,882
+48,552
+86% +$6.27M ﹤0.01% 2051
2024
Q2 		$9.21M Buy
56,330
+5,676
+11% +$809K ﹤0.01% 2040
2024
Q1 		$7.72M Sell
50,654
-1,762
-3% -$293K ﹤0.01% 2208
2023
Q4 		$16.4M Sell
52,416
-910
-2% -$329K ﹤0.01% 1751
2023
Q3 		$23.7M Buy
53,326
+1,659
+3% +$749K ﹤0.01% 1432
2023
Q2 		$22.4M Buy
51,667
+14,976
+41% +$8.42M ﹤0.01% 1509
2023
Q1 		$21.8M Buy
36,691
+1,265
+4% +$709K ﹤0.01% 1502
2022
Q4 		$14.3M Buy
35,426
+426
+1% +$200K ﹤0.01% 1768
2022
Q3 		$20.5M Buy
35,000
+12,441
+55% +$7.45M ﹤0.01% 1448
2022
Q2 		$12.3M Buy
22,559
+6,080
+37% +$3.08M ﹤0.01% 1872
2022
Q1 		$10.4M Buy
16,479
+718
+5% +$370K ﹤0.01% 2119
2021
Q4 		$10.6M Buy
15,761
+7,254
+85% +$4.41M ﹤0.01% 2188
2021
Q3 		$5.57M Sell
8,507
-2,296
-21% -$1.96M ﹤0.01% 2653
2021
Q2 		$11M Buy
+10,803
New +$9.46M ﹤0.01% 2301

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust's AGL Position: Q2 2026 in Review

Northern Trust increased its Agilon Health (AGL) stake by 7.6% in Q2 2026, buying an estimated $480K and bringing the position to 103,432 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

Northern Trust first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $23.7M in Q3 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Northern Trust held 103,432 shares of Agilon Health worth $11.1M as of Q2 2026.
  • Northern Trust bought 7,332 Agilon Health shares in Q2 2026, an estimated $480K.
  • Agilon Health made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2167 holding.
  • Northern Trust first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • Northern Trust's Agilon Health position peaked at $23.7M in Q3 2023.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.